Literature DB >> 14991251

Stability and activity of an Enterobacter aerogenes-specific bacteriophage under simulated gastro-intestinal conditions.

K Verthé1, S Possemiers, N Boon, M Vaneechoutte, W Verstraete.   

Abstract

A bacteriophage, designated UZ1 and showing lytic activity against a clinically important strain (BE1) of Enterobacter aerogenes was isolated from hospital sewage. The stability and lytic activity against this strain under simulated gastro-intestinal conditions was evaluated. After addition of bacteriophage UZ1 to a liquid feed at gastric pH 2, the phage was immediately inactivated and could not be recovered. However, by use of an antacid to neutralize stomach acidity, no significant changes in phage titer were observed after 2 h incubation at 37 degrees C. After supplementing pancreatic juice and further incubation for 4 h, the phage titer remained stable. The persistence of UZ1 in a mixed microbial ecosystem that was representative for the large intestine was monitored using an in vitro simulation of the human intestinal microbial ecosystem. A pulse administration of bacteriophage UZ1 at a concentration of 10(5) plaque-forming units (PFU)/ml to reactor 3 (which simulates the ascending colon) showed that, in the absence of the host, bacteriophage UZ1 persisted for 13 days in the simulated colon, while the theoretical washout was calculated at 16 days. To assess its lytic activity in an intestinal microbial ecosystem, a green fluorescent protein (gfp)-labeled E. aerogenes BE1 strain was constructed and gfp-specific primers were designed in order to quantify the host strain using real-time PCR. It was observed that bacteriophage UZ1 was able to replicate and showed lytic activity against E. aerogenes BE1/ gfp in an intestinal microbial ecosystem. Indeed, after 17 h a 2 log unit reduction of E. aerogenes BE1/ gfp was measured as compared with the assay without bacteriophage UZ1, while the phage titer increased by 2 log units at an initial multiplicity of infection of 0.07 PFU/colony-forming unit. This is the first report of an in vitro model to study bacteriophage activity in the complex intestinal microbial community.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14991251     DOI: 10.1007/s00253-004-1585-7

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  15 in total

Review 1.  Ménage à trois in the human gut: interactions between host, bacteria and phages.

Authors:  Mohammadali Khan Mirzaei; Corinne F Maurice
Journal:  Nat Rev Microbiol       Date:  2017-05-02       Impact factor: 60.633

Review 2.  Pharmacologically Aware Phage Therapy: Pharmacodynamic and Pharmacokinetic Obstacles to Phage Antibacterial Action in Animal and Human Bodies.

Authors:  Krystyna Dąbrowska; Stephen T Abedon
Journal:  Microbiol Mol Biol Rev       Date:  2019-10-30       Impact factor: 11.056

3.  Survival and Metabolic Activity of Pediocin Producer Pediococcus acidilactici UL5: Its Impact on Intestinal Microbiota and Listeria monocytogenes in a Model of the Human Terminal Ileum.

Authors:  Benoît Fernandez; Patricia Savard; Ismail Fliss
Journal:  Microb Ecol       Date:  2015-07-11       Impact factor: 4.552

4.  Evaluation of Phage Delivery Systems on Induced Motile Aeromonas Septicemia in Oreochromis niloticus.

Authors:  Kathleen May C Gordola; Fatima Alesandra U Boctuanon; Raylene Audrey A Diolata; Maria Bernadette D Pedro; Tracey Antaeus D Gutierrez; Rey Donne S Papa; Donna May D Papa
Journal:  Phage (New Rochelle)       Date:  2020-12-16

5.  Biogenic silver for disinfection of water contaminated with viruses.

Authors:  Bart De Gusseme; Liesje Sintubin; Leen Baert; Ellen Thibo; Tom Hennebel; Griet Vermeulen; Mieke Uyttendaele; Willy Verstraete; Nico Boon
Journal:  Appl Environ Microbiol       Date:  2009-12-28       Impact factor: 4.792

6.  Prophylactic Bacteriophage Administration More Effective than Post-infection Administration in Reducing Salmonella enterica serovar Enteritidis Shedding in Quail.

Authors:  Mosab Ahmadi; M Amir Karimi Torshizi; Shaban Rahimi; John J Dennehy
Journal:  Front Microbiol       Date:  2016-08-09       Impact factor: 5.640

7.  Isolation and characterization of a bacteriophage phiEap-2 infecting multidrug resistant Enterobacter aerogenes.

Authors:  Erna Li; Xiao Wei; Yanyan Ma; Zhe Yin; Huan Li; Weishi Lin; Xuesong Wang; Chao Li; Zhiqiang Shen; Ruixiang Zhao; Huiying Yang; Aimin Jiang; Wenhui Yang; Jing Yuan; Xiangna Zhao
Journal:  Sci Rep       Date:  2016-06-20       Impact factor: 4.379

Review 8.  Semi-Solid and Solid Dosage Forms for the Delivery of Phage Therapy to Epithelia.

Authors:  Teagan L Brown; Steve Petrovski; Hiu Tat Chan; Michael J Angove; Joseph Tucci
Journal:  Pharmaceuticals (Basel)       Date:  2018-02-26

9.  Isolation of Dickeya dadantii strains from potato disease and biocontrol by their bacteriophages.

Authors:  Abbas Soleimani-Delfan; Zahra Etemadifar; Giti Emtiazi; Majid Bouzari
Journal:  Braz J Microbiol       Date:  2015-07-01       Impact factor: 2.476

Review 10.  Bacteriophage Procurement for Therapeutic Purposes.

Authors:  Beata Weber-Dąbrowska; Ewa Jończyk-Matysiak; Maciej Żaczek; Małgorzata Łobocka; Marzanna Łusiak-Szelachowska; Andrzej Górski
Journal:  Front Microbiol       Date:  2016-08-12       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.